Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07392580 · ClinicalTrials.gov registry record · Phase 2
Intralesional Chemotherapy (IC): Cisplatin + Epinephrine
A Phase 2 study, sponsored by University of Miami.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT07392580 is a Phase 2 study that is actively recruiting participants, run by University of Miami. The registered enrollment target is 20 participants.
The verdict
NCT07392580, a Phase 2 study, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects, good and bad, of injecting chemotherapy into recurrent laryngeal squamous cell carcinoma (SCC) tumors.
Interventions
- DRUG Cisplatin
- DRUG Epinephrine injection
- PROCEDURE Laryngeal Biopsy
- PROCEDURE Endoscopic Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2031-09-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07392580
The ClinicalTrials.gov registry entry for NCT07392580 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Cisplatin is the first listed.
NCT07392580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07392580 about?
NCT07392580 is a clinical study titled "Intralesional Chemotherapy (IC): Cisplatin + Epinephrine". The purpose of this study is to determine the effects, good and bad, of injecting chemotherapy into recurrent laryngeal squamous cell carcinoma (SCC) tumors.
What is the current status of trial NCT07392580?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2026-09-01. Estimated completion is 2031-09-01.
What interventions are being tested in trial NCT07392580?
The interventions under investigation include: Cisplatin (DRUG), Epinephrine injection (DRUG), Laryngeal Biopsy (PROCEDURE), Endoscopic Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT07392580?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.